Macquarie Group’s G Medical Innovations Holdings Ltd. Ordinary Shares GMVD Stock Holding History

Macquarie Group’s Portfolio GMVD Stock Details GMVD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-2,925	Closed	-$169	–	1712
2023 Q3	$169	Hold	2,925	–	–	﹤0.01%	1639
2023 Q2	$1.13K	Hold	2,925	–	–	﹤0.01%	1651
2023 Q1	$2.66K	Hold	2,925	–	–	﹤0.01%	1698
2022 Q4	$9.51K	Buy	2,925 +1	+0%	+$5	﹤0.01%	1721
2022 Q3	$24K	Buy	+2,924	New	+$43K	﹤0.01%	2155

Macquarie Group's GMVD Position: Q4 2023 in Review

Macquarie Group sold out of G Medical Innovations Holdings Ltd. Ordinary Shares (GMVD) in Q4 2023, closing a stake of 2,925 shares — an estimated $169 sold.

Macquarie Group first reported a position in GMVD in Q3 2022 and held it in 5 quarters. The position peaked at $24K in Q3 2022. 0 funds tracked by Wall St. Rank hold GMVD as of Q4 2023.

Macquarie Group reported no remaining G Medical Innovations Holdings Ltd. Ordinary Shares position as of Q4 2023 after selling out during the quarter.
Macquarie Group sold 2,925 G Medical Innovations Holdings Ltd. Ordinary Shares shares in Q4 2023, an estimated $169.
Macquarie Group first reported a position in G Medical Innovations Holdings Ltd. Ordinary Shares in Q3 2022 and held it in 5 quarters.
Macquarie Group's G Medical Innovations Holdings Ltd. Ordinary Shares position peaked at $24K in Q3 2022.
0 funds tracked by Wall St. Rank held G Medical Innovations Holdings Ltd. Ordinary Shares as of Q4 2023.

Based on Macquarie Group's 13F filing for Q4 2023, filed 14 Feb 2024.